SEC form
4
Accepted by SEC
08 Jun 2022, 21:49:09 UTC
Prior SEC filing
19 May 2022
Next SEC filing
23 Jun 2023
Source filing
View source filing
Filing notes and source

Key filing fact

Joseph Lind filed Form 4 for Neuberger Berman High Yield Strategies Fund Inc. (NHS) on 08 Jun 2022.

Key facts

  • This page summarizes Joseph Lind's Form 4 filing for Neuberger Berman High Yield Strategies Fund Inc. (NHS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jun 2022, 21:49.

Change

  • Previous filing in this sequence was filed on 19 May 2022.
  • Current net transaction value: +$91,952.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHS transaction

Common Stock

Purchase

Transaction value
$46,238
Shares
+5,000
Change %
+50%
Price
$9.25
Shares after
15,000
Date
06 Jun 2022
Ownership
Direct
Footnotes
F1, F2
NHS transaction

Common Stock

Purchase

Transaction value
$45,714
Shares
+5,000
Change %
+33%
Price
$9.14
Shares after
20,000
Date
07 Jun 2022
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares were purchased in separate transactions. The range of prices for the transactions reported on this line was $9.22 to $9.29. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

On May 19, 2022, the Reporting Person filed a Form 4 reporting an acquisition of 5,000 shares of common stock that did not in fact occur due to administrative error. As of May 19, 2022, the Reporting Person owned only 10,000 shares of common stock. Following the transaction on June 6, 2022 reported in this Form 4, the Reporting Person owned 15,000 shares of common stock.

Footnote F3

The shares were purchased in separate transactions. The range of prices for the transactions reported on this line was $9.13 to $9.15. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .